ERBB2 and breast cancer: LC-MS/MS was used to identify BC related salivary proteins that are modulated secondary to ductal carcinoma in situ (DCIS) of the breast [37] as well as for detection of overexpressed and downregulated proteins from saliva of patients with either HER2/neu positive or negative [36].